The anti-IgA/IgG secondary antibody allows the simultaneous detection of IgG and IgA antibodies which is practical and increases the sensitivity as most sera from patients with BP and MMP[33,56,57]) and many sera from patients with EBA contain IgA autoantibodies in addition to IgG reactivity[58]. The gene discussed is CD79A; the disease is acquired epidermolysis bullosa.